Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erminio Bonizzoni

Showing results (81-90 of 87) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 87 results.
The Oncologist|June 8, 2021
Dexamethasone-Sparing Regimens with Oral Netupitant and Palonosetron for the Prevention of Emesis Caused by High-Dose Cisplatin: A Randomized Noninferiority StudyLuigi Celio, Diego Cortinovis, Alessio Aligi Cogoni, et al.
BMC Cancer|August 23, 2022
Evaluating the impact of chemotherapy-induced nausea and vomiting on daily functioning in patients receiving dexamethasone-sparing antiemetic regimens with NEPA (netupitant/palonosetron) in the cisplatin setting: results from a randomized phase 3 studyLuigi Celio, Diego Cortinovis, Alessio Aligi Cogoni, et al.
Scientific Reports|January 23, 2023
Exploratory analysis of the effect of a dexamethasone-sparing regimen for prophylaxis of cisplatin-induced emesis on food intake (LUNG-NEPA study)Luigi Celio, Diego Cortinovis, Alessio Aligi Cogoni, et al.
Circulation|June 20, 2007
Favorable long-term outcome after drug-eluting stent implantation in nonbifurcation lesions that involve unprotected left main coronary artery: a multicenter registryAlaide Chieffo, Seung J Park, Marco Valgimigli, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 17, 2021
Efficacy and safety of netupitant/palonosetron combination (NEPA) in preventing nausea and vomiting in non-Hodgkin's lymphoma patients undergoing to chemomobilization before autologous stem cell transplantationNicola Di Renzo, Maurizio Musso, Rosanna Scimè, et al.
British Journal of Haematology|October 13, 2015
Improved outcome of patients with relapsed/refractory Hodgkin lymphoma with a new fotemustine-based high-dose chemotherapy regimenMaurizio Musso, Giuseppe Messina, Nicola Di Renzo, et al.
European Heart Journal|June 21, 2008
Late and very late stent thrombosis following drug-eluting stent implantation in unprotected left main coronary artery: a multicentre registryAlaide Chieffo, Seung-Jung Park, Emanuele Meliga, et al.
Pageof 9

Showing results (81-90 of 87) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 87 results.
The Oncologist|June 8, 2021
Dexamethasone-Sparing Regimens with Oral Netupitant and Palonosetron for the Prevention of Emesis Caused by High-Dose Cisplatin: A Randomized Noninferiority StudyLuigi Celio, Diego Cortinovis, Alessio Aligi Cogoni, et al.
BMC Cancer|August 23, 2022
Evaluating the impact of chemotherapy-induced nausea and vomiting on daily functioning in patients receiving dexamethasone-sparing antiemetic regimens with NEPA (netupitant/palonosetron) in the cisplatin setting: results from a randomized phase 3 studyLuigi Celio, Diego Cortinovis, Alessio Aligi Cogoni, et al.
Scientific Reports|January 23, 2023
Exploratory analysis of the effect of a dexamethasone-sparing regimen for prophylaxis of cisplatin-induced emesis on food intake (LUNG-NEPA study)Luigi Celio, Diego Cortinovis, Alessio Aligi Cogoni, et al.
Circulation|June 20, 2007
Favorable long-term outcome after drug-eluting stent implantation in nonbifurcation lesions that involve unprotected left main coronary artery: a multicenter registryAlaide Chieffo, Seung J Park, Marco Valgimigli, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 17, 2021
Efficacy and safety of netupitant/palonosetron combination (NEPA) in preventing nausea and vomiting in non-Hodgkin's lymphoma patients undergoing to chemomobilization before autologous stem cell transplantationNicola Di Renzo, Maurizio Musso, Rosanna Scimè, et al.
British Journal of Haematology|October 13, 2015
Improved outcome of patients with relapsed/refractory Hodgkin lymphoma with a new fotemustine-based high-dose chemotherapy regimenMaurizio Musso, Giuseppe Messina, Nicola Di Renzo, et al.
European Heart Journal|June 21, 2008
Late and very late stent thrombosis following drug-eluting stent implantation in unprotected left main coronary artery: a multicentre registryAlaide Chieffo, Seung-Jung Park, Emanuele Meliga, et al.
Pageof 9